Cleared Traditional

K161724 - Visicoil MR Marker (User Loaded), Visicoil MR Marker (Pre-Loaded)

K161724 is an FDA 510(k) clearance for Visicoil MR Marker (User Loaded), manufactured by Radiomed Corporation. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 310-day FDA review.

K161724 · Radiomed Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2017
Decision
310d
Days
Class 2
Risk

K161724 is an FDA 510(k) clearance for the Visicoil MR Marker (User Loaded), Visicoil MR Marker (Pre-Loaded). Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Radiomed Corporation (Bartlett, US). The FDA issued a Cleared decision on April 28, 2017 after a review of 310 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Radiomed Corporation devices

FDA 510(k) Submission Details - K161724

510(k) Number K161724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 22, 2016
Decision Date April 28, 2017
Days to Decision 310 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
203d slower than avg
Panel avg: 107d · This submission: 310d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 540
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K161724.
Accuray Precision Treatment Planning System
K171086 · Accuray Incorporated · Jun 2017
MRIdian Linac System with 138-leaf Collimator
K170751 · Viewray, Incorporated · Jun 2017
BEAMSCAN
K161807 · Ptw-Freiburg Physikalisch Technische-Werksraetten · May 2017
CyberKnife Treatment Delivery System
K170788 · Accuray Incorportaed · Apr 2017
TheraView TBI
K170058 · Cablon Medical B.V. · Mar 2017
The ViewRay (MRIdian) Linac System
K162393 · Viewray, Incorporated · Feb 2017